HUNTSVILLE, Ala. – Sept. 29, 2025 – Glaukos Corporation (NYSE: GKOS), a leading ophthalmic pharmaceutical and medical technology company, has officially broken ground on a new research and manufacturing campus in Cummings Research Park, one of the nation’s largest technology and innovation hubs.
The state-of-the-art facility will focus on advancing therapies for glaucoma, corneal disorders, and retinal diseases, underscoring Glaukos’ commitment to driving innovation in eye health.
A Strategic Investment in U.S. Innovation
Glaukos is investing more than $80 million in the Huntsville project, which will include a 200,000-square-foot facility on a 25-acre site, with an option for 15 additional acres to accommodate future expansion.
“We are proud to expand our U.S. footprint with the development of this new state-of-the-art facility to augment our current infrastructure and support our long-term growth plans, underscoring our commitment to American manufacturing and the critical role it plays in advancing healthcare innovation,” said Thomas Burns, Chairman and CEO of Glaukos. “After evaluating over 100 potential sites worldwide, we ultimately chose Huntsville for its strong talent base and vibrant business climate.”
Huntsville’s Innovation Ecosystem
The City of Huntsville welcomed Glaukos’ investment as another milestone in the region’s growth as a hub for advanced manufacturing and biotechnology.
“For decades, Huntsville has worked to build an environment where science, technology and advanced manufacturing thrive together in a community that knows how to support discovery,” said Huntsville Mayor Tommy Battle. “Glaukos’ decision to grow here builds on that foundation, showing how our community’s strengths attract companies that are shaping the future of human health around the world.”
Expanding Global Impact
Headquartered in Aliso Viejo, California, Glaukos develops and commercializes novel therapies and medical technologies that address some of the most prevalent and serious eye conditions worldwide. The new Huntsville campus represents a strategic step in the company’s long-term growth and manufacturing capabilities.
The groundbreaking marks the beginning of a new chapter for Glaukos in Huntsville, combining world-class science with the region’s thriving innovation ecosystem to advance next-generation solutions in ophthalmology.
